Abstract Type 1 Interferons (IFNs) have been associated with positive effects on
Coronaviruses. Previous studies point towards the superior potency of IFNβ compared to …

The scientific community is focused on developing antiviral therapies to mitigate the impacts
of the ongoing novel coronavirus disease 2019 (COVID-19) outbreak. This will be facilitated …

Objectives Patients with colorectal cancer (CRC) may be susceptible to the coronavirus
disease-2019 (COVID-19). However, anti-CRC/COVID-19 treatment options are currently …

Background There is no effective therapy for COVID-19. Hydroxychloroquine (HCQ) and
chloroquine (CQ) have been used for its treatment but their safety and efficacy remain …

There are currently no proven or approved treatments for coronavirus disease 2019 (COVID‐
19). Early anecdotal reports and limited in vitro data led to the significant uptake of …

Background Although coronavirus disease 2019 (COVID-19) is mild in nearly all children, a
small proportion of pediatric patients develop severe or critical illness. Guidance is therefore …

Background In the ongoing COVID-19 pandemic, the susceptibility of patients with rheumatic
diseases to COVID-19 remains unclear. We aimed to investigate susceptibility to COVID-19 …

In the last few months, the number of cases of a new coronavirus-related disease (COVID-
19) rose exponentially, reaching the status of a pandemic. Interestingly, early imaging …

Abstract Coronavirus disease 2019 (COVID‐19) has spread worldwide. To date, no specific
drug for COVID‐19 has been developed. Thus, this randomized, open‐label, controlled …

We conducted this systemic review and meta‐analysis in an attempt to evaluate the efficacy
and safety of umifenovir in coronavirus disease 2019 (COVID‐19). We searched PubMed …